A biotech firm that moved its headquarters to Cincinnati last year is raising millions in fresh funding as it continues to build out its portfolio and grow key operations in the city.
Orange Grove Bio, which calls University of Cincinnati’s 1819 Innovation Hub home, is looking to raise $30 million, per a filing in late August with U.S. Securities and Exchange Commission. The notice shows more than half, or $16.5 million has been sold to date, with roughly $13.4 million remaining.
Click here to read the complete story.
Story excerpt provided by Cincy Inno.
Written by Liz Engel.
Originally published September 8, 2022.